Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biliary Fistula | 1 | 2019 | 38 | 0.640 |
Why?
|
| Bile | 1 | 2019 | 299 | 0.600 |
Why?
|
| Cholangitis | 1 | 2019 | 110 | 0.600 |
Why?
|
| Intensive Care Units | 2 | 2023 | 3800 | 0.590 |
Why?
|
| Focus Groups | 2 | 2024 | 1461 | 0.580 |
Why?
|
| Analgesia | 1 | 2020 | 460 | 0.520 |
Why?
|
| Pleural Effusion | 1 | 2019 | 345 | 0.510 |
Why?
|
| Arabinonucleosides | 1 | 2014 | 34 | 0.460 |
Why?
|
| Adenine Nucleotides | 1 | 2014 | 110 | 0.460 |
Why?
|
| Abdomen | 1 | 2020 | 1137 | 0.450 |
Why?
|
| Academic Medical Centers | 2 | 2023 | 2784 | 0.430 |
Why?
|
| Drainage | 1 | 2019 | 1184 | 0.430 |
Why?
|
| Learning | 2 | 2019 | 1761 | 0.360 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2014 | 647 | 0.350 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 2145 | 0.320 |
Why?
|
| Transplantation Conditioning | 1 | 2014 | 1601 | 0.280 |
Why?
|
| Opioid-Related Disorders | 1 | 2020 | 2189 | 0.250 |
Why?
|
| Internship and Residency | 2 | 2023 | 5956 | 0.240 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3253 | 0.240 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 1936 | 0.190 |
Why?
|
| Respiration, Artificial | 2 | 2020 | 2724 | 0.160 |
Why?
|
| Thoracostomy | 1 | 2019 | 79 | 0.160 |
Why?
|
| Positive-Pressure Respiration | 2 | 2020 | 713 | 0.150 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3116 | 0.150 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2020 | 389 | 0.150 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3239 | 0.150 |
Why?
|
| Naltrexone | 1 | 2020 | 319 | 0.150 |
Why?
|
| Shock | 1 | 2019 | 316 | 0.140 |
Why?
|
| Pressure | 1 | 2020 | 1172 | 0.140 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 452 | 0.130 |
Why?
|
| Internal Medicine | 1 | 2024 | 1064 | 0.130 |
Why?
|
| Angiotensin II | 1 | 2019 | 844 | 0.130 |
Why?
|
| Respiratory Mechanics | 1 | 2020 | 722 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 5716 | 0.130 |
Why?
|
| Nurses | 1 | 2023 | 2501 | 0.110 |
Why?
|
| Respiration | 1 | 2020 | 1668 | 0.110 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2014 | 330 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2020 | 1190 | 0.100 |
Why?
|
| Pandemics | 3 | 2020 | 8745 | 0.100 |
Why?
|
| Teaching | 1 | 2019 | 1171 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2023 | 3143 | 0.100 |
Why?
|
| Kidney Function Tests | 1 | 2014 | 684 | 0.100 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2014 | 640 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 1241 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2024 | 3626 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2014 | 1645 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2020 | 1541 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2023 | 3925 | 0.080 |
Why?
|
| Desiccation | 1 | 2008 | 77 | 0.080 |
Why?
|
| Indicators and Reagents | 1 | 2008 | 455 | 0.070 |
Why?
|
| Critical Illness | 1 | 2020 | 2754 | 0.070 |
Why?
|
| Vasoconstrictor Agents | 2 | 2020 | 657 | 0.070 |
Why?
|
| Middle Aged | 5 | 2023 | 223740 | 0.060 |
Why?
|
| Transplantation, Homologous | 1 | 2014 | 4835 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 2422 | 0.060 |
Why?
|
| Immunoassay | 1 | 2008 | 746 | 0.060 |
Why?
|
| Humans | 13 | 2024 | 768887 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 3837 | 0.060 |
Why?
|
| Microfluidics | 1 | 2008 | 674 | 0.050 |
Why?
|
| Hematologic Neoplasms | 1 | 2014 | 1907 | 0.050 |
Why?
|
| Male | 5 | 2023 | 365249 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 10097 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2017 | 4859 | 0.050 |
Why?
|
| Prone Position | 1 | 2020 | 203 | 0.040 |
Why?
|
| Catecholamines | 1 | 2019 | 390 | 0.040 |
Why?
|
| Adult | 4 | 2023 | 223818 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2020 | 282 | 0.040 |
Why?
|
| Patient Positioning | 1 | 2020 | 332 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 1169 | 0.030 |
Why?
|
| Reference Standards | 1 | 2020 | 1014 | 0.030 |
Why?
|
| Fluid Therapy | 1 | 2020 | 587 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15955 | 0.030 |
Why?
|
| Developing Countries | 1 | 2008 | 2906 | 0.030 |
Why?
|
| Knowledge | 1 | 2017 | 178 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2020 | 990 | 0.030 |
Why?
|
| Electronic Mail | 1 | 2017 | 215 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20776 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 2020 | 812 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 30044 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 1359 | 0.030 |
Why?
|
| Female | 3 | 2023 | 397464 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2017 | 1260 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2020 | 1943 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 1483 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 74971 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 171790 | 0.020 |
Why?
|
| Plasmodium | 1 | 2008 | 248 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10591 | 0.020 |
Why?
|
| Smoking | 1 | 2020 | 9094 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 5892 | 0.010 |
Why?
|
| Hypertension | 1 | 2020 | 8615 | 0.010 |
Why?
|
| Physicians | 1 | 2017 | 4607 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 41800 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 59738 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 60110 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 9499 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 81892 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 169408 | 0.000 |
Why?
|
Concepts
(98)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_